The FDA does not evaluate over-the-counter dietary supplements for safety or efficacy before they are sold
New Human-Use Patent Claims The newly filed applications include claims directed to the potential use of EL-22 and EL-32 to preserve lean muscle mass in patients undergoing obesity-related weight loss treatment, including GLP-1 receptor agonists and dual and triple agonist therapies targeting the GLP-1, GIP, and glucagon pathways
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
May your calculations stay accurate, your concentrations stay verified, and your results stay consistent.
Semaglutide carries a boxed warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and is contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Patients with prediabetes or new-onset diabetes should receive individualized medical nutrition therapy, preferably from a registered dietitian, as needed to achieve treatment goals
